Division of Nephrology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Registre de Dialyse Péritonéale de Langue française (RDPLF), Pontoise, France.
Hemodial Int. 2022 Jul;26(3):295-307. doi: 10.1111/hdi.13014. Epub 2022 Apr 19.
Home hemodialysis (HHD) remains underused in patients with kidney failure. Current literature on HHD mostly originates from non-European countries, making generalization difficult. The present study describes patients' profile and practice patterns from a Belgian HHD center, and assesses patient and technique survival and complications associated with HHD.
We analyzed data from all our incident patients during a 6-year period. The patient's characteristics were summarized using descriptive statistics. Transition to another therapeutic modality, estimated using a risk model with death and transplantation as competing events, episodes of respite cares and hospitalizations, and access complications were analyzed.
Eighty patients (mean age: 47 years; male: 64%) met the inclusion criteria. Fifty-one percent of patients initiated dialysis with a central venous catheter (CVC) and 96% were not assisted. Arterio-venous fistula (AVF) cannulation was performed using buttonhole technique. Standard-frequent HD (47%) and short-frequent low-flow dialysate HD (34%) were mostly used at HHD initiation. Cumulative incidences of technique failure and death were 15%, 24%, and 32% at 1, 2, and 5 years. Incidence rates for respite dialysis and hospitalizations were 2.39 and 0.54 per patient-year of HHD. In comparison with AVF, incidence rate ratios of overall access complications and access-related infections for CVC were 4.3 (95% CI: 3.1-6, p < 0.01) and 4.4 (95% CI: 2.1-10, p < 0.01), respectively. Buttonhole cannulation was complicated by 0.26 (95% CI: 0.15-0.46) infections per 1000 AVF-days.
This present study provides important information about patient's profile and practice patterns and safety in a cohort of 80 incident Belgian HHD patients, with encouraging techniques and patient survival.
在肾衰竭患者中,家庭血液透析(HHD)的应用仍然不足。目前关于 HHD 的文献主要来自非欧洲国家,因此难以推广。本研究描述了来自比利时 HHD 中心的患者情况和实践模式,并评估了 HHD 相关的患者和技术生存率以及并发症。
我们分析了 6 年内所有新发病例患者的数据。使用描述性统计方法总结患者特征。使用包含死亡和移植作为竞争事件的风险模型分析转为另一种治疗方式、间歇护理和住院的发作以及血管通路并发症。
80 名(平均年龄:47 岁;男性:64%)符合纳入标准的患者。51%的患者开始透析时使用中心静脉导管(CVC),96%的患者未接受辅助治疗。动静脉瘘(AVF)穿刺采用扣眼技术。标准频繁血液透析(47%)和短频繁低流量透析液血液透析(34%)是 HHD 开始时最常用的方法。1、2 和 5 年时技术失败和死亡的累积发生率分别为 15%、24%和 32%。间歇透析和住院的发生率分别为每例患者每年 2.39 和 0.54 次。与 AVF 相比,CVC 的总体血管通路并发症和与血管通路相关感染的发生率比值分别为 4.3(95%CI:3.1-6,p<0.01)和 4.4(95%CI:2.1-10,p<0.01)。扣眼穿刺技术导致每 1000 个 AVF 日发生 0.26(95%CI:0.15-0.46)次感染。
本研究为 80 名比利时新发病例 HHD 患者的患者情况和实践模式以及安全性提供了重要信息,技术和患者生存率令人鼓舞。